October 2024 FDA Recall Chlorpheniramine Maleate 4mg by Bli International, Inc.
D-0029-2025 - Superpotent Drug

This Class II drug recall was voluntarily initiated by Bli International, Inc. on October 21, 2024 for the product Chlorpheniramine Maleate 4mg. The FDA reported the reason for recall as superpotent drug. The product was distributed in Product was shipped to two private label customers ( OH & MO) as a final packaged product. and the recall is currently terminated.

Recall Number: D-0029-2025

Reason for Recall
Superpotent Drug: Stability failure for assay at 6 months test time-point.
Initiated
10-21-2024
Reported
11-06-2024
Quantity
4,901 cases/24 count each case

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
BLI International, Inc.
Product was shipped to two private label customers ( OH & MO) as a final packaged product.
Chlorpheniramine Maleate 4 mg tablets, 24-count bottle, Manufactured For: Athlete's Needs, Novi, MI 48377, NDC 53185-277-24

Batch or Lot Expiration Information

Lot# 24A27724, Exp 01/31/2027

Affected Packages Involved in this Recall